아즈말라늄,4-(3-(디에틸아미노)-2-히드록시프로필)-17,21-디히드록시-,(17R,21알파)-,(2R,3R)-2,3-디히드록시부탄디오산과의염(1:1),월무수화물

아즈말라늄,4-(3-(디에틸아미노)-2-히드록시프로필)-17,21-디히드록시-,(17R,21알파)-,(2R,3R)-2,3-디히드록시부탄디오산과의염(1:1),월무수화물
아즈말라늄,4-(3-(디에틸아미노)-2-히드록시프로필)-17,21-디히드록시-,(17R,21알파)-,(2R,3R)-2,3-디히드록시부탄디오산과의염(1:1),월무수화물 구조식 이미지
카스 번호:
53862-81-0
한글명:
아즈말라늄,4-(3-(디에틸아미노)-2-히드록시프로필)-17,21-디히드록시-,(17R,21알파)-,(2R,3R)-2,3-디히드록시부탄디오산과의염(1:1),월무수화물
동의어(한글):
아즈말라늄,4-(3-(디에틸아미노)-2-히드록시프로필)-17,21-디히드록시-,(17R,21알파)-,(2R,3R)-2,3-디히드록시부탄디오산과의염(1:1),월무수화물
상품명:
Ajmalanium, 4-(3-(diethylamino)-2-hydroxypropyl)-17,21-dihydroxy-, (17 R,21alpha)-, salt with (2R,3R)-2,3-dihydroxybutanedioic acid (1:1), mo nohydrate
동의어(영문):
Detajmiumbitartrat;Detajmium bitartrate [inn];Detajmium bitartrate hydrate;4-(3'-Diethylamino-2'-hydroxypropyl)ajmaline hydrogen tartrate;Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, ion(1-), (17R,21alpha)-4-(3-(diethylamino)-2-hydroxypropyl)-17,21-dihydroxyajmalanium, monohydrate;Butanedioic acid, 2,3-dihydroxy-(R-(R*,R*))-, ion(1-), (17R,21alpha)-4-(3-(diethylamino)-2-hydroxypropyl)-17,21-dihydroxyajmalanium, monohydrate;Ajmalanium, 4-(3-(diethylamino)-2-hydroxypropyl)-17,21-dihydroxy-, (17 R,21alpha)-, salt with (2R,3R)-2,3-dihydroxybutanedioic acid (1:1), mo nohydrate;Ajmalanium, 4-(3-(diethylamino)-2-hydroxypropyl)-17,21-dihydroxy-, (17R,21alpha)-, salt with (R-(R*,R*))-2,3-dihydroxybutanedioic acid (1:1), monohydrate
CBNumber:
CB41244814
분자식:
C31H47N3O9
포뮬러 무게:
605.73
MOL 파일:
53862-81-0.mol

아즈말라늄,4-(3-(디에틸아미노)-2-히드록시프로필)-17,21-디히드록시-,(17R,21알파)-,(2R,3R)-2,3-디히드록시부탄디오산과의염(1:1),월무수화물 속성

안전

아즈말라늄,4-(3-(디에틸아미노)-2-히드록시프로필)-17,21-디히드록시-,(17R,21알파)-,(2R,3R)-2,3-디히드록시부탄디오산과의염(1:1),월무수화물 C화학적 특성, 용도, 생산

아즈말라늄,4-(3-(디에틸아미노)-2-히드록시프로필)-17,21-디히드록시-,(17R,21알파)-,(2R,3R)-2,3-디히드록시부탄디오산과의염(1:1),월무수화물 준비 용품 및 원자재

원자재

준비 용품


아즈말라늄,4-(3-(디에틸아미노)-2-히드록시프로필)-17,21-디히드록시-,(17R,21알파)-,(2R,3R)-2,3-디히드록시부탄디오산과의염(1:1),월무수화물 공급 업체

글로벌( 1)공급 업체
공급자 전화 이메일 국가 제품 수 이점
HONEST JOY HOLDINGS LIMITED --
sales@honestjoy.cn United States 6702 54

Copyright 2019 © ChemicalBook. All rights reserved